(+) |
positive-sense |
(−) |
negative-sense |
APC |
Antigen-presenting cell |
BC |
Baltimore Class |
CDDI |
Cortellis Drug Discovery Intelligence |
CDKis |
CDK inhibitors |
CDKs |
Cyclin-dependent kinases |
GAK |
Cyclin G associated kinase (GAK) |
DAA |
Direct acting antiviral |
ds |
double-stranded |
FDA |
Food and Drug Administration |
FDR |
False discovery rate |
HAND |
HIV-1-associated neurocognitive disorders |
HTA |
Host targeted antiviral |
ICTV |
International Committee on Taxonomy of Viruses |
KEGG |
Kyoto Encyclopedia of Genes and Genomes |
MAPK |
Mitogen-activated protein kinase |
MLKL |
Mixed lineage kinase-like protein |
PKC |
Protein kinase C |
PKR |
Protein kinase RNA-activated |
PRR |
Pattern recognition receptors |
R&D |
Research and development |
RdRp |
RNA-dependent RNA polymerase |
RIG-1 |
Retinoic acid-inducible gene 1 |
RIPK |
Receptor interacting protein kinase |
RLR |
Retinoic acid-inducible gene 1(RIG-I)-like receptor |
RT |
reverse transcribing |
RTK |
Receptor tyrosine kinase |
RTz |
Reverse transcriptase enzyme |
ss |
single-stranded |
TLR |
Toll-like receptor |
UAD |
Under active development |